Int J STD AIDS. 2003 Oct;14 Suppl 1:34-6.

The Assessing Patients' Preferred Treatments (APPT-1) study.

Source

HIV Research Department, Chelsea and Westminster Hospital, London, UK. gm@moyle.demon.co.uk

Abstract

Limited information is currently available on patient preferences regarding administration frequency, tablet load and the trade-off between side effects and convenience in choosing antiretroviral regimens. A standardized questionnaire of persons with HIV infection across 5 large European countries was used to assess patient preference. 504 people with HIV participated. Participants showed a preference for once-daily therapy administration. However, several factors affected this preference.

PMID:: 14617402; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

Anti-HIV Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Related citations

The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey. [AIDS Patient Care STDS. 2005]
The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey.
Sherer RD Jr, Fath MJ, Da Silva BA, Nicolau AM, Miller NL. AIDS Patient Care STDS. 2005 Dec; 19(12):794-802.
Patient preferences regarding antiretroviral therapy. [Int J STD AIDS. 2002]
Patient preferences regarding antiretroviral therapy.
Miller LG, Huffman HB, Weidmer BA, Hays RD. Int J STD AIDS. 2002 Sep; 13(9):593-601.
Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. [J Acquir Immune Defic Syndr. 2004]
Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
Stone VE, Jordan J, Tolson J, Miller R, Pilon T. J Acquir Immune Defic Syndr. 2004 Jul 1; 36(3):808-16.
Review Once-daily therapy: less is more. [Int J STD AIDS. 2003]
Review Once-daily therapy: less is more.
Moyle G. Int J STD AIDS. 2003 Oct; 14 Suppl 1:1-5.
Review Efficacy and safety of once-daily regimens in the treatment of HIV infection. [Drugs. 2008]
Review Efficacy and safety of once-daily regimens in the treatment of HIV infection.
Molina JM. Drugs. 2008; 68(5):567-78.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Efavirenz: a decade of clinical experience in the treatment of HIV. [J Antimicrob Chemother. 2009]
Review Efavirenz: a decade of clinical experience in the treatment of HIV.
Maggiolo F. J Antimicrob Chemother. 2009 Nov; 64(5):910-28. Epub 2009 Sep 18.
Osteoporosis medication profile preference: results from the PREFER-US study. [Health Expect. 2007]
Osteoporosis medication profile preference: results from the PREFER-US study.
Weiss TW, McHorney CA. Health Expect. 2007 Sep; 10(3):211-23.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The Assessing Patients' Preferred Treatments (APPT-1) study.
The Assessing Patients' Preferred Treatments (APPT-1) study.
Int J STD AIDS. 2003 Oct ;14 Suppl 1:34-6.

PubMed
Human papillomavirus-associated cancers in patients with human immunodeficiency ...
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.
J Natl Cancer Inst. 2000 Sep 20 ;92(18):1500-10.

PubMed
Buruli ulcer: progress report, 2004-2008.
Buruli ulcer: progress report, 2004-2008.
Wkly Epidemiol Rec. 2008 Apr 25 ;83(17):145-54.

PubMed
Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
J Rheumatol Suppl. 2007 Nov ;80:25-33.

PubMed
Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppres...
Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.
Stem Cells. 2009 Sep ;27(9):2342-52.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: